Status:
COMPLETED
Obstructive Sleep Apnoea in Adolescents With Thoracic Aortic Aneurysm
Lead Sponsor:
University of Zurich
Conditions:
Thoracic Aortic Aneurysm Without Rupture
Obstructive Sleep Apnea
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this prospective cohort study is to determine the prevalence of obstructive sleep apnoea (OSA) in patients with and without thoracic aortic aneurysm.
Detailed Description
The objective of this prospective cohort study is to determine the prevalence of obstructive sleep apnoea (OSA) in patients with and without thoracic aortic aneurysm.
Eligibility Criteria
Inclusion
- Age \> 18 years.
- Diagnosis of thoracic aortic aneurysm defined by the following parameters:
- Women: at the level of the sinus of valsalva ≥39mm, or ascending aorta ≥42mm. (for controls: \<39mm and \<42mm respectively); Men: at the level of the sinus of valsalva ≥44mm, or ascending aorta ≥46mm. (for controls: \<44mm and \<46mm respectively)
Exclusion
- Patients on continuous positive airway pressure (CPAP) therapy for OSA at baseline.
- Patients with known central sleep apnoea.
- Patients on morphine or other opioid medication, heroin addiction, alcohol addiction.
- Patients with moderate or severe aortic regurgitation.
- Patients with moderate or severe aortic stenosis.
- Pregnant patients.
Key Trial Info
Start Date :
July 5 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT03400319
Start Date
July 5 2014
End Date
March 1 2020
Last Update
May 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich, Pulmonary Division
Zurich, Switzerland, 8091